Better disease prediction, faster and at lower cost
- 70% Accuracy predicting disease 10 years ahead
- 2M Parameter model—small, fast, and cost-effective
- 3 days From publication to running live on Teradata
Researchers at the European Molecular Biology Laboratory and the German Cancer Research Center developed Delphi 2M—a small language model adapted to predict the diseases a patient will develop up to 10 years in the future, with up to 70% accuracy. Teradata's forward-deployed engineering team, leveraging nPath and Bring Your Own Model (BYOM) technologies, had the model running on Teradata just three days after it was published—demonstrating the speed and power of Teradata's AI platform for healthcare innovation.
Caring for aging populations across many geographies places mounting pressure on healthcare systems to plan services more accurately and cost-effectively. Traditional demand forecasting methods lack the predictive depth needed to anticipate which services different patient cohorts will require—and when. Meanwhile, deploying AI in large enterprises has historically been bottlenecked by the high cost of inference at scale, making large language models impractical for many real-world healthcare applications.
Delphi 2M's researchers made a clever architectural innovation: replacing the positional encoding in a standard transformer model—which tracks word order in a sentence—with age encoding that tracks a patient's timeline. Fed with restructured longitudinal patient data, the resulting model can predict future disease onset with remarkable accuracy. Teradata's BYOM technology enabled the engineering team to deploy this small, fine-tuned model directly in-database, while nPath provided the sequencing analytics needed to structure patient journey data—all operational within three days of the paper's release.
While Delphi 2M is still early-stage research and not yet cleared for individual clinical use, it’s already accurate enough for aggregate demand forecasting—helping healthcare systems anticipate which services different cohorts will need across different regions. Running on Teradata, the model delivers this at a fraction of the cost and complexity of large language model alternatives, with the potential to fundamentally transform how health systems plan and fund care.
Find out how Teradata helps you accelerate business outcomes and provide the business agility you need.
Our sales representatives are here to help.